Job Watch

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Funding Opportunity PAR-19-274 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Funding Opportunity PAR-19-275 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-276 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

EMBL: Scientific Training Officer

New Scientist - Bioinformatics - Wed, 2019-05-08 05:38
Competitive Salary: EMBL: Scientific Training Officer Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-278 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes. It is expected that any genetic resources generated will be made broadly available to the scientific community to enable investigation of the relevant neurobiological mechanisms involved and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.

Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional)

Funding Opportunity RFA-DA-20-012 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit research applications for commercializable, blockchain-based products that aim to improve the inefficient processes currently in existence within the SUD healthcare ecosystem.

Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional)

Funding Opportunity RFA-DA-20-011 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit research applications for commercializable, blockchain-based products that aim to improve the inefficient processes currently in existence within the SUD healthcare ecosystem

Genentech, Inc.: PHC Sr. Data Scientist

New Scientist - Bioinformatics - Tue, 2019-05-07 20:45
Competitive Salary: Genentech, Inc.: Genentech seeks Senior Data Scientist for the Personalized HealthCare group with responsibility for real world evidence strategies. South San Francisco, California
Categories: Job Watch

The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)

Funding Opportunity RFA-GM-19-002 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the NIGMS Human Genetic Cell Repository (HGCR). The repository will maintain the current collection of cell cultures and DNA samples and will acquire, characterize, and expand high-quality cell samples, and distribute cell lines and DNA isolated from them to qualified biomedical researchers.

HHS issues Four (4) PHS 2019-2 SBIR and STTR Omnibus/Parent Grant Solicitations

Notice NOT-OD-19-105 from the NIH Guide for Grants and Contracts

PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required

Funding Opportunity PA-19-271 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2019-2 SBIR/STTR Program Descriptions and Research Topics for NIH. This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

Pages

Subscribe to Anil Jegga aggregator - Job Watch